Experimental determination and calculations of redox potential descriptors of compounds directed against retroviral zinc fingers: Implications for rational drug design

A diverse set of electrophilic compounds that react with cysteine thiolates in retroviral nucleocapsid (NC) proteins and abolish virus infectivity has been identified. Although different in chemical composition, these compounds are all oxidizing agents that lead to the ejection of Zn(II) ions bound to conserved structural motifs (zinc fingers) present in retroviral NC proteins. The reactivity of a congeneric series of aromatic disulfides toward the NC protein of the human immunodeficiency virus type 1 (HIV‐1), NCp7, has been characterized by HPLC separation of starting reagents from reaction products. We calculated the absolute redox potentials of these compounds in the gas phase and in aqueous solvent, using a density functional theory method and a continuum solvation model. Pulsed polarography experiments were performed and showed a direct correlation between calculated and experimentally determined redox propensities. A dependence between protein reactivity and redox potential for a specific compound was shown: Reaction with NCp7 did not take place below a threshold value of redox potential. This relationship permits the distinction between active and nonactive compounds targeted against NCp7, and provides a theoretical basis for a scale of reactivity with retroviral zinc fingers. Our results indicate that electrophilic agents with adequate thiophilicity to react with retroviral NC fingers can now be designed using known or calculated electrochemical properties. This may assist in the design of antiretroviral compounds with greater specificity for NC protein. Such electrophilic agents can be used in retrovirus inactivation with the intent of preparing a whole‐killed virus vaccine formulation that exhibits unaffected surface antigenic properties.

[1]  R. Gorelick,et al.  Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[2]  L. Arthur,et al.  Suppression of retrovirial replication: inactivation of murine leukemia virus by compounds reacting with the zinc finger in the viral nucleocapsid protein. , 1997, Leukemia.

[3]  M. Chance,et al.  Extended x-ray absorption fine structure studies of a retrovirus: equine infectious anemia virus cysteine arrays are coordinated to zinc. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[4]  L. Arthur,et al.  Inactivation of murine leukemia virus by compounds that react with the zinc finger in the viral nucleocapsid protein , 1996, Journal of virology.

[5]  Michael A. Bukatin,et al.  Incorporation of reaction field effects into density functional calculations for molecules of arbitrary shape in solution , 1994 .

[6]  L. Arthur,et al.  Probing the topography of HIV-1 nucleocapsid protein with the alkylating agent N-ethylmaleimide. , 1998, Biochemistry.

[7]  B. Kho,et al.  Pulse polarographic determination of disulfiram. , 1972, Journal of pharmaceutical sciences.

[8]  N. Russo,et al.  Protonation of glycine and alanine: proton affinities, intrinsic basicities and proton transfer path , 1998 .

[9]  Y. Hathout,et al.  Characterization of intermediates in the oxidation of zinc fingers in human immunodeficiency virus type 1 nucleocapsid protein P7. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[10]  R. Friesner,et al.  Ab Initio Electronic Structure Calculation of the Redox Potentials of Bacteriochlorophyll and Bacteriopheophytin in Solution , 1995 .

[11]  R. Gorelick,et al.  Binding properties of the human immunodeficiency virus type 1 nucleocapsid protein p7 to a model RNA: elucidation of the structural determinants for function. , 1999, Journal of molecular biology.

[12]  Q. Sattentau,et al.  Inactivation of Human Immunodeficiency Virus Type 1 Infectivity with Preservation of Conformational and Functional Integrity of Virion Surface Proteins , 1998, Journal of Virology.

[13]  Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution‐state structure of the nucleocapsid protein from HIV‐1 , 1992, Protein science : a publication of the Protein Society.

[14]  W. Alvord,et al.  Inhibition of Friend virus replication by a compound that reacts with the nucleocapsid zinc finger: anti-retroviral effect demonstrated in vivo. , 1998, Virology.

[15]  D. Gallant,et al.  Antabuse (disulfiram) and AIDS. , 1991, Alcoholism, clinical and experimental research.

[16]  Erich Wimmer,et al.  Density functional Gaussian‐type‐orbital approach to molecular geometries, vibrations, and reaction energies , 1992 .

[17]  G. Patriarche,et al.  Contribution à l'électrochimie des thiols et disulfures. Partie II. Polarographie d.c., a.c. et impulsionnelle différentielle du glutathion , 1975 .

[18]  A. Leo,et al.  Substituent constants for correlation analysis in chemistry and biology , 1979 .

[19]  M. Reily,et al.  Biophysical characterization of zinc ejection from HIV nucleocapsid protein by anti-HIV 2,2'-dithiobis[benzamides] and benzisothiazolones. , 1996, Journal of medicinal chemistry.

[20]  O. Foss IONIC SCISSION OF THE SULFUR-SULFUR BOND , 1961 .

[21]  J. Lifson,et al.  Strict conservation of the retroviral nucleocapsid protein zinc finger is strongly influenced by its role in viral infection processes: characterization of HIV-1 particles containing mutant nucleocapsid zinc-coordinating sequences. , 1999, Virology.

[22]  L. Arthur,et al.  Inhibitors of HIV Nucleocapsid Protein Zinc Fingers as Candidates for the Treatment of AIDS , 1995, Science.

[23]  L. Arthur,et al.  The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent , 1993, Journal of virology.

[24]  J. Lifson,et al.  Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: a candidate SIV vaccine. , 1998, AIDS research and human retroviruses.

[25]  L. Arthur,et al.  Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA , 1990, Journal of virology.

[26]  M. Summers,et al.  Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds , 1993, Nature.

[27]  M. Summers,et al.  Zinc ejection as a new rationale for the use of cystamine and related disulfide-containing antiviral agents in the treatment of AIDS. , 1997, Journal of medicinal chemistry.

[28]  A. Rashin,et al.  Aspects of protein energetics and dynamics. , 1993, Progress in biophysics and molecular biology.

[29]  A. Becke Density-functional thermochemistry. III. The role of exact exchange , 1993 .

[30]  J. Perdew,et al.  Density-functional approximation for the correlation energy of the inhomogeneous electron gas. , 1986, Physical review. B, Condensed matter.

[31]  J. Auger,et al.  Formation of stable aryldisulphide ions in dimethylacetamide from the reaction of sulphur with thiolate ions , 1990 .

[32]  A. Kaiser,et al.  Long‐term Antabuse treatment: tolerance and reasons for withdrawal , 1992, Acta psychiatrica Scandinavica. Supplementum.

[33]  M. Schwartz,et al.  Distinct functions and requirements for the Cys-His boxes of the human immunodeficiency virus type 1 nucleocapsid protein during RNA encapsidation and replication , 1997, Journal of virology.

[34]  Modification of Cysteine , 1996, Current protocols in protein science.

[35]  G. Patriarche,et al.  Contribution a l'électrochimie des thiols et disulfures : Partie IV. Polarographies d.c., a.c., impulsionnelle différentielle et voltamétrie cyclique du disulfiram , 1976 .

[36]  E. Barklis,et al.  Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation , 1995, Journal of virology.

[38]  R. Gorelick,et al.  Human immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract , 1996, Journal of virology.

[39]  D. Gallant,et al.  Tetrahydropapaveroline and alcohol preference. , 1991, Alcoholism, clinical and experimental research.

[40]  M. Kester,et al.  Suppression of retrovirial replication: inactivation of murine leukemia virus by compounds reacting with the zinc finger in the viral nucleocapsid protein. , 1997 .

[41]  Stanley K. Burt,et al.  Triazene proton affinities: A comparison between density functional, Hartree–Fock, and post‐Hartree–Fock methods , 1994, J. Comput. Chem..

[42]  R. Gorelick,et al.  Evidence that a central domain of nucleocapsid protein is required for RNA packaging in murine leukemia virus , 1994, Journal of virology.

[43]  D. Covell,et al.  Reactivity of the HIV-1 nucleocapsid protein p7 zinc finger domains from the perspective of density-functional theory. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  R. Young,et al.  Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus , 1990, Journal of virology.

[45]  J. Erickson,et al.  A quantum-mechanical study of metal binding sites in zinc finger structures , 1998 .

[46]  Parr,et al.  Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. , 1988, Physical review. B, Condensed matter.

[47]  P. Dupraz,et al.  Point mutations in the proximal Cys-His box of Rous sarcoma virus nucleocapsid protein , 1990, Journal of virology.

[48]  A. Becke Density-functional thermochemistry. , 1996 .